Global Dermatology Drugs Market Size By Application (Acne, Dermatitis, Psoriasis, Skin Cancer), By Route of Administration (Topical, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Geographic Scope And Forecast

Report ID: 289596|No. of Pages: 202

product image

Global Dermatology Drugs Market Size By Application (Acne, Dermatitis, Psoriasis, Skin Cancer), By Route of Administration (Topical, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Geographic Scope And Forecast

Report ID: 289596|Published Date: Jan 2024|No. of Pages: 202|Base Year for Estimate: 2022|Format:   Report available in PDF formatReport available in Excel Format

Dermatology Drugs Market Size And Forecast

Dermatology Drugs Market size was valued at USD 18.83 Billion in 2022 and is projected to reach USD 42.77 Billion by 2030, growing at a CAGR of 10.80% from 2023 to 2030.

The availability of medical resources for diagnosing and treating skin conditions, nutritional deficiencies brought on by unhealthful eating habits, growing awareness of lifestyle diseases, rising pollution levels, and a lack of population immunity are some of the driving factors expected to contribute to the growth of the global market for dermatology drugs. The expanding purchasing power and rising per capita income are other driving factors in this industry.

>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=289596

Dermatology Drugs Market is estimated to grow at a CAGR of 10.80% & reach US$ 42.77 Bn by the end of 2030

Global Dermatology Drugs Market Definition

Dermatology is a field of medicine that focuses on identifying, preventing, and treating conditions that affect the skin, including those that affect the hair and nails. Medications used to treat skin conditions are referred to as dermatology drugs. Drugs used in dermatology are intended to prevent skin conditions. Laser therapy, topical and systemic drugs, photodynamic therapy, radiation, vitiligo surgery, and dermatological surgery are all forms of skin treatment.

These dermatology drugs are also applied topically to the skin to preserve attributes like radiance and health. The market for dermatology drugs is made up of companies (organizations, sole proprietors, and partnerships) that sell the medications they make to treat skin conditions. This sector of the economy is made up of businesses that manufacture medications to treat conditions like rosacea, dermatitis, hyperhidrosis, androgenic alopecia, acne, microbial infections, and other skin disorders.

Global Dermatology Drugs Market Overview

With more people suffering from dermatitis, fungal infections, and acne, the market for dermatological drugs is growing. The American Association of Dermatologists reports that approximately 50 million people in the US alone suffer from acne. Numerous factors, such as poor self-care, excessive sweating, eating hot foods, and donning restrictive clothing, can result in skin problems and other related problems. The market is seeing an increase in the sales of medicines used for treatments as a result. Increased public awareness of skin and hair infections has been shown to create an opportunity for the sector. Increased awareness has led to an increase in the sales of over-the-counter (OTC) drugs, which are widely used to treat hair loss and acne. Most children and teenagers experience skin issues like irritation, acne, and excessive sweating as a result of hormonal changes.

The market is expected to keep growing because of the rise in demand for dermatological drugs that are frequently applied topically as anti-inflammatory agents and cleansers. As a result of the growing demand for novel, effective, and reasonably priced medicines, additional factors to take into account include a growth in R&D spending by industry leaders for the development and clinical testing of new treatments. The pharmaceutical sector is growing as cases of skin cancer and other diseases are on the rise. However, the sector won’t be able to reach its full potential due to a variety of negative effects and inappropriate administration of dermatological treatments, as well as regulatory restrictions and standards.

Global Dermatology Drugs Market: Segmentation Analysis

The Global Dermatology Drugs Market Segmented On The Basis Of Application, Route of Administration, Distribution Channel, and Geography.

Dermatology Drugs Market Segmentation Analysis

Dermatology Drugs Market, By Application

  • Acne
  • Dermatitis
  • Psoriasis
  • Skin Cancer
  • Others

Based on Application, The market is bifurcated into Acne, Dermatitis, Psoriasis, Skin Cancer, and Others. In 2021, the market was dominated by the psoriasis category in terms of revenue. The immune system mistakenly attacks healthy skin cells, which results in psoriasis. Psoriasis is not a disease that spreads easily. Swollen fingers and toes, foot pain, lower back pain, nail changes, and eye irritation are all symptoms of the disease. Stress, skin injuries, infections, some medicines, and heavy drinking can all cause psoriasis. Although it affects people of all ages, psoriasis is most common in adults, which increases the demand for dermatology drugs globally.

Dermatology Drugs Market, By Route of Administration

  • Topical
  • Oral
  • Parenteral Administration

Based on Route of Administration, The market is bifurcated into Topical, Oral, and Parenteral Administration. The parenteral administration market segment completely dominated in 2021. The segment’s dominance is due to the development of biologics for the treatment of dermatological conditions. Additionally, it is projected that increased patient demand for tropical therapies will boost the products’ sales. Because oral medications have been approved by the US FDA, it is anticipated that the oral category would see a significant CAGR during the projected period.

Dermatology Drugs Market, By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Based on Distribution Channel, The market is bifurcated into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The Hospital Pharmacies segment has the largest share of the Global Dermatology Drugs Market as a result of an increase in patient visits and sales of prescription-only drugs for the treatment of dermatological skin diseases. This market is growing as a result of consumers’ preference for neighborhood pharmacies and the availability of low-cost OTC products. Over the course of the anticipated period, it is estimated that the online pharmacies market would expand at a profitable CAGR due to the extensive use of online portals and websites like Amazon and Walmart.

Dermatology Drugs Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East And Africa

On the basis of Regional Analysis, The Global Dermatology Drugs Market is segmented on the basis of geography into North America, Europe, Asia Pacific, Latin America, Middle East And Africa. Over the forecast period, Asia Pacific is anticipated to experience the highest CAGR growth. The most populous countries in the globe, such as China and India, are anticipated to have a high number of skin disease patients during the projection period. The highest growth in this market is being attributed to factors such as health services, life science industry advancements, and increased awareness of skin conditions and their treatments. Additionally, this industry is expanding at a fast rate due to rising incomes and consumer power.

Key Players

The “Global Dermatology Drugs Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Novartis AG, Amgen Inc., AbbVie Inc., Johnson & Johnson, Leo Pharma A/S, Eli Lilly and Company, GlaxoSmithKline Plc, AstraZeneca plc, Pfizer Inc., Merck KGaA. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Report Scope

REPORT ATTRIBUTESDETAILS
Study Period

2019-2030

Base Year

2022

Forecast Period

2023-2030

Historical Period

2019-2021

Unit

Value (USD Billion)

Key Companies Profiled

Novartis AG, Amgen Inc., AbbVie Inc., Johnson & Johnson, Leo Pharma A/S, Eli Lilly and Company, GlaxoSmithKline Plc, AstraZeneca plc, Pfizer Inc.

Segments Covered

By Application, By Route of Administration, By Distribution Channel, and By Geography.

Customization scope

Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Top Trending Reports:

Global Veterinary Dermatology Drugs Market Size And Forecast

Global Clinical Trial Consumables Market Size And Forecast

Research Methodology of Verified Market Research:

Research Methodology of VMR

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

Frequently Asked Questions

Dermatology Drugs Market was valued at USD 18.83 Billion in 2022 and is projected to reach USD 42.77 Billion by 2030, growing at a CAGR of 10.80% from 2023 to 2030.

The expanding purchasing power and rising per capita income are other driving factors in this industry.

The major players are Novartis AG, Amgen Inc., AbbVie Inc., Johnson & Johnson, Leo Pharma A/S, Eli Lilly and Company, GlaxoSmithKline Plc, AstraZeneca plc, Pfizer Inc., Merck KGaA.

The Global Dermatology Drugs Market Segmented On The Basis Of Application, Route of Administration, Distribution Channel, and Geography.

The sample report for the Dermatology Drugs Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.
1 INTRODUCTION OF GLOBAL DERMATOLOGY DRUGS MARKET 1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions 2 EXECUTIVE SUMMARY 3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH 3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources 4 GLOBAL DERMATOLOGY DRUGS MARKET OUTLOOK 4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis 5 GLOBAL DERMATOLOGY DRUGS MARKET, BY APPLICATION 5.1 Overview 5.2 Acne 5.3 Dermatitis 5.4 Psoriasis 5.5 Skin Cancer 5.6 Others 6 GLOBAL DERMATOLOGY DRUGS MARKET, BY ROUTE OF ADMINISTRATION 6.1 Overview 6.2 Topical 6.3 Oral 6.4 Parenteral Administration 7 GLOBAL DERMATOLOGY DRUGS MARKET, BY DISTRIBUTION CHANNEL 7.1 Overview 7.2 Hospital Pharmacies 7.3 Retail Pharmacies 7.4 Online Pharmacies 8 GLOBAL DERMATOLOGY DRUGS MARKET, BY GEOGRAPHY 8.1 Overview 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 U.K. 8.3.3 France 8.3.4 Spain 8.3.5 Italy 8.3.6 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Rest of Asia Pacific 8.5 Latin America 8.5.1 Brazil 8.5.2 Argentina 8.5.3 Rest of Latin America 8.6 Middle East & Africa 8.6.1 Saudi Arabia 8.6.2 UAE 8.6.3 South Africa 8.6.4 Rest of Middle East and Africa 9 GLOBAL DERMATOLOGY DRUGS MARKET COMPETITIVE LANDSCAPE 9.1 Overview 9.2 Company Market Ranking 9.3 Key Development Strategies 10 COMPANY PROFILES 10.1 Novartis AG 10.1.1 Overview 10.1.2 Financial Performance 10.1.3 Product Outlook 10.1.4 Key Developments 10.2 Amgen Inc. 10.2.1 Overview 10.2.2 Financial Performance 10.2.3 Product Outlook 10.2.4 Key Developments 10.3 AbbVie Inc. 10.3.1 Overview 10.3.2 Financial Performance 10.3.3 Product Outlook 10.3.4 Key Developments 10.4 Johnson & Johnson 10.4.1 Overview 10.4.2 Financial Performance 10.4.3 Product Outlook 10.4.4 Key Developments 10.5 Leo Pharma A/S 10.5.1 Overview 10.5.2 Financial Performance 10.5.3 Product Outlook 10.5.4 Key Developments 10.6 Eli Lilly and Company 10.6.1 Overview 10.6.2 Financial Performance 10.6.3 Product Outlook 10.6.4 Key Developments 10.7 GlaxoSmithKline Plc 10.7.1 Overview 10.7.2 Financial Performance 10.7.3 Product Outlook 10.7.4 Key Developments 10.8 AstraZeneca plc 10.8.1 Overview 10.8.2 Financial Performance 10.8.3 Product Outlook 10.8.4 Key Developments 10.9 Pfizer Inc 10.9.1 Overview 10.9.2 Financial Performance 10.9.3 Product Outlook 10.9.4 Key Developments 10.10 Merck KGaA 10.10.1 Overview 10.10.2 Financial Performance 10.10.3 Product Outlook 10.10.4 Key Developments 11 Appendix 11.1 Related Research

Report Research Methodology

Research methodology

Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.

This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.

We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:

Exploratory data mining

Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.

All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.

expert data mining

For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.

Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.

Data Collection Matrix

PerspectivePrimary ResearchSecondary Research
Supplier side
  • Fabricators
  • Technology purveyors and wholesalers
  • Competitor company’s business reports and newsletters
  • Government publications and websites
  • Independent investigations
  • Economic and demographic specifics
Demand side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customer

Econometrics and data visualization model

data visualiztion model

Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.

All the research models are customized to the prerequisites shared by the global clients.

The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.

Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.

Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.

Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:

  • Market drivers and restraints, along with their current and expected impact
  • Raw material scenario and supply v/s price trends
  • Regulatory scenario and expected developments
  • Current capacity and expected capacity additions up to 2027

We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.

Primary validation

The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.

The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.

primary validation

Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:

  • Established market players
  • Raw data suppliers
  • Network participants such as distributors
  • End consumers

The aims of doing primary research are:

  • Verifying the collected data in terms of accuracy and reliability.
  • To understand the ongoing market trends and to foresee the future market growth patterns.

Industry Analysis Matrix

Qualitative analysisQuantitative analysis
  • Global industry landscape and trends
  • Market momentum and key issues
  • Technology landscape
  • Market’s emerging opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2027
  • Market revenue estimates and forecasts up to 2027, by technology
  • Market revenue estimates and forecasts up to 2027, by application
  • Market revenue estimates and forecasts up to 2027, by type
  • Market revenue estimates and forecasts up to 2027, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Dermatology Drugs Market

report-detail

Download Sample Report

View More Reports